---

title: "Mapping the complexity of ME/CFS: Evidence for abnormal energy metabolism, altered immune profile, and vascular dysfunction."
tags:
- ‚ûï 2025-12-25
- üß™ Biomarker
- ‚≠ê Landmark
created: '2025-12-16'
published: '2025-12-16'

---


<details>
<summary>Heng et al. (2025)</summary>

- **Authors:** Benjamin Heng, Bavani Gunasegaran, Shivani Krishnamurthy, Sergio Bustamante, Anne S. Pires, Steven Chow, Sang-Beom Ahn, Melanie Paul-Heng, Yvonne Maciver, Karen Smith, Dan P. Tran, Peter P. Howley, A. Ayse Bilgin, Alexandra Sharland, Richard Schloeffel, Gilles J. Guillemin.
- **Institutes:** Macquarie Medical School, Macquarie University, Sydney, Australia; Charles Perkins Centre, The University of Sydney, Australia; Royal North Shore Hospital, St Leonards, Australia.
- **Publisher:** Cell Reports Medicine
- **Link:** [DOI](https://doi.org/10.1016/j.xcrm.2025.102514)

</details>


## Summary

This research is significant because it provides a "map" of how different biological problems in ME/CFS connect to one another. By showing that energy failures in cells, immature immune profiles, and blood vessel issues coexist, it offers a more comprehensive explanation for why patients experience such a wide range of debilitating symptoms. The identification of a specific set of biological markers is a major step toward developing an objective blood test for diagnosis. While no new treatments were tested in this specific study, the results help narrow down exactly where future drugs need to intervene to restore normal cellular and vascular function.

## What was researched?

This study conducted a multi-system analysis to investigate how energy metabolism, immune system function, and blood vessel (vascular) health are simultaneously affected in individuals with ME/CFS. The goal was to identify coordinated biological patterns that could explain the disease‚Äôs complex symptoms and provide a basis for new diagnostic tools.

## Why was it researched?

While many studies have examined single biological issues in ME/CFS‚Äîsuch as mitochondrial dysfunction or immune abnormalities‚Äîfew have looked at how these systems interact within the same group of patients. Because ME/CFS affects multiple organs and systems, the researchers hypothesized that a "multi-omics" approach (looking at metabolites, proteins, and cells at once) would reveal a more complete picture of the disease's underlying biology.

## How was it researched?

This was a multimodal clinical study involving 61 ME/CFS patients (diagnosed using established clinical criteria) and 61 age- and sex-matched healthy controls. The researchers analyzed blood samples using three primary methods: metabolomics to measure energy molecules like ATP, flow cytometry to profile immune cell maturity, and proteomics to identify plasma proteins related to vascular health. They then used a machine-learning technique called "classification and regression tree" (CART) modeling to determine which biological markers could most accurately distinguish patients from healthy individuals.

## What has been found?

The study found evidence of significant "energy stress" in the immune cells of ME/CFS patients, characterized by high levels of AMP and ADP and a reduced ATP/ADP ratio, indicating a struggle to generate cellular energy. The immune system showed a skewing toward less mature versions of T cells, dendritic cells, and natural killer cells, suggesting an impaired immune response. Furthermore, plasma analysis revealed elevated proteins associated with thrombus (blood clot) formation and vascular reactivity, which point toward endothelial dysfunction (problems with the lining of the blood vessels). The researchers identified a set of seven key biological variables that could potentially predict ME/CFS with high accuracy.

## Discussion

The authors emphasize that ME/CFS is a multi-system disorder where metabolic, immune, and vascular dysfunctions are likely linked. They note that the energy deficit in immune cells may be driven by mitochondrial issues, such as increased mitochondrial fission, while the vascular findings align with patient reports of "brain fog" and poor circulation. A primary limitation is the need for these findings to be validated in even larger, independent groups of patients to ensure the predictive model is reliable for clinical use.

## Conclusion & Future Work

The authors conclude that ME/CFS involves a coordinated breakdown across energy, immune, and vascular systems rather than a single isolated defect. They suggest that future treatments should likely target all three areas simultaneously to be effective. Future research will focus on validating the seven-variable diagnostic model and investigating whether these biological signatures change over the course of the illness.
